FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40112111000001102: Eslicarbazepine 200mg tablets (Aristo Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2043051000001118 Eslicarbazepine 200mg tablets (Aristo Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2043061000001115 Eslicarbazepine 200mg tablets (Aristo Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eslicarbazepine 200mg tablets (Aristo Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Eslicarbazepine 200mg tablets (Aristo Pharma Ltd) Is a Eslicarbazepine 200mg tablets true Inferred relationship Existential restriction modifier
Eslicarbazepine 200mg tablets (Aristo Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Eslicarbazepine 200mg tablets (Aristo Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Eslicarbazepine 200mg tablets (Aristo Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Eslicarbazepine 200mg tablets (Aristo Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Eslicarbazepine 200mg tablets (Aristo Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Eslicarbazepine 200mg tablets (Aristo Pharma Ltd) Has specific active ingredient Eslicarbazepine acetate true Inferred relationship Existential restriction modifier
Eslicarbazepine 200mg tablets (Aristo Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Eslicarbazepine 200mg tablets (Aristo Pharma Ltd) 60 tablet 4 x 15 tablets Has AMP True Eslicarbazepine 200mg tablets (Aristo Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start